A Study of Minirin Melt in Patients With Nocturia

NCT ID: NCT01222598

Last Updated: 2012-10-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

588 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-09-30

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a confirmation of safety profile for Minirin Melt in clinical practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nocturia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients suffering from Nocturia

Exclusion Criteria

* habitual or psychogenic polydipsia
* known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics
* moderate and severe renal insufficiency
* know hyponatremia
* syndrome of inappropriate ADH secretion
Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ferring Pharmaceuticals

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Development Support

Role: STUDY_DIRECTOR

Ferring Pharmaceuticals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Private Ambulance

Blansko, , Czechia

Site Status

Private Ambulance

Brno, , Czechia

Site Status

Trauma Hospital in Brno

Brno, , Czechia

Site Status

Urocentrum

Brno, , Czechia

Site Status

Uromeda, s.r.o.

Brno, , Czechia

Site Status

Private Ambulance

Brno-Zábrdovice, , Czechia

Site Status

Private Ambulance

Bystřice pod Hostýnem, , Czechia

Site Status

Hospital Dečín

Děčín, , Czechia

Site Status

University Hospital Hradec Králové

Hradec Králové, , Czechia

Site Status

Hospital Jablonec nad Nisou

Jablonec nad Nisou, , Czechia

Site Status

Hospital Jihlava

Jihlava, , Czechia

Site Status

Hospital Kroměříž

Kroměříž, , Czechia

Site Status

Polyclinic Kuřim

Kuřim, , Czechia

Site Status

Private Ambulance

Moravský Krumlov, , Czechia

Site Status

Hospital Nové Město na Moravě

Nové Město na Moravě, , Czechia

Site Status

Hospital with Polyclinic Nový Jičín

Nový Jičín, , Czechia

Site Status

Private Ambulance

Nový Jičín, , Czechia

Site Status

University Hospital Olomouc

Olomouc, , Czechia

Site Status

City Hospital Ostrava

Ostrava, , Czechia

Site Status

Hospital Ostrava

Ostrava, , Czechia

Site Status

Private Ambulance

Ostrava, , Czechia

Site Status

Central Military Hospital

Prague, , Czechia

Site Status

Medicon, s.r.o.

Prague, , Czechia

Site Status

Polyclinic Barandov

Prague, , Czechia

Site Status

Private Ambulance

Prague, , Czechia

Site Status

Railway Hospital

Prague, , Czechia

Site Status

Thomayer´s Hospital

Prague, , Czechia

Site Status

University Hospital Bulovka

Prague, , Czechia

Site Status

Hospital Prostějov

Prostějov, , Czechia

Site Status

Private Ambulance

Přerov, , Czechia

Site Status

Hospital Šumperk

Šumperk, , Czechia

Site Status

Private Ambulance

Třebíč, , Czechia

Site Status

Hospital Uherské Hradiště

Uherské Hradiště, , Czechia

Site Status

Hospital Ústí nad Orlicí, Inc

Ústí nad Orlicí, , Czechia

Site Status

Hospital Valašské Meziříčí, Inc

Valašské Meziříčí, , Czechia

Site Status

T. Bata Regional Hospital, Inc.

Zlín, , Czechia

Site Status

Hospital Znojmo

Znojmo, , Czechia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FE992026 CS38

Identifier Type: -

Identifier Source: org_study_id